Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
32. lappuse
... flask . After 60 minutes , accu- rately timed , withdraw 25 milliliters , using a glass syringe connected to a glass sampling tube , of solution from a point midway between the stirring shaft and the wall of the vessel , and ap ...
... flask . After 60 minutes , accu- rately timed , withdraw 25 milliliters , using a glass syringe connected to a glass sampling tube , of solution from a point midway between the stirring shaft and the wall of the vessel , and ap ...
303. lappuse
... flask and fill the flask to the mark with distilled water . Mix and filter through a dry filter paper into a dry vessel . Transfer exactly 40 milliliters of the filtrate to a flask , add 2 milli- liters of ferric ammonium sulfate test ...
... flask and fill the flask to the mark with distilled water . Mix and filter through a dry filter paper into a dry vessel . Transfer exactly 40 milliliters of the filtrate to a flask , add 2 milli- liters of ferric ammonium sulfate test ...
356. lappuse
... flask . ) Stopper the flask and swirl to dissolve the drug . As soon as the sample has completely dissolved , proceed as di- rected in paragraph ( e ) ( 1 ) ( ii ) of this section . If the pooled portions from 20 containers will not ...
... flask . ) Stopper the flask and swirl to dissolve the drug . As soon as the sample has completely dissolved , proceed as di- rected in paragraph ( e ) ( 1 ) ( ii ) of this section . If the pooled portions from 20 containers will not ...
390. lappuse
... flask . Add 5 milliliters of 0.1N hydrochloric acid and swirl the flask to dissolve oxy- tetracycline base . Dilute an accurately measured portion with distilled water to obtain a known concentration of 0.01 to 0.02 milligram of ...
... flask . Add 5 milliliters of 0.1N hydrochloric acid and swirl the flask to dissolve oxy- tetracycline base . Dilute an accurately measured portion with distilled water to obtain a known concentration of 0.01 to 0.02 milligram of ...
391. lappuse
... flask . Dissolve and dilute to volume with 0.12N hydrochloric acid . Further dilute with a buffer solution ( prepared by dis- solving 27.2 grams of sodium acetate trihydrate in a mixture of 12 milliliters of glacial acetic acid and ...
... flask . Dissolve and dilute to volume with 0.12N hydrochloric acid . Further dilute with a buffer solution ( prepared by dis- solving 27.2 grams of sodium acetate trihydrate in a mixture of 12 milliliters of glacial acetic acid and ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning